Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Buccisano

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Frontiers in Immunology|January 1, 2025
Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasmsMichele Pitaro, Giovanni Antonini, Alessandro Arcovito, et al.
Mycoses|December 9, 2021
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemiaGiovangiacinto Paterno, Luca Guarnera, Raffaele Palmieri, et al.
Therapeutic Advances in Hematology|October 14, 2021
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendationsMonica Carpenedo, Erminia Baldacci, Claudia Baratè, et al.
Blood|November 9, 2002
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)Giovanni Del Poeta, Adriano Venditti, Maria Ilaria Del Principe, et al.
Journal of Immunological Methods|October 4, 2005
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevanceAntonella Zucchetto, Paolo Sonego, Massimo Degan, et al.
Future Oncology (London, England)|July 13, 2021
AMELIORATE: early intensification in <i>FLT3</i>-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trialFrancesco Mannelli, Giacomo Gianfaldoni, Paola Guglielmelli, et al.
Cancers|January 28, 2026
Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML PatientsElisa Buzzatti, Cristina Mauro, Cristiano Tesei, et al.
Cancer|July 16, 2011
Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate ProgramLuca Maurillo, Adriano Venditti, Alessandra Spagnoli, et al.
Journal of Clinical Medicine|February 26, 2025
Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of ResponseValeria Mezzanotte, Giovangiacinto Paterno, Ilaria Cerroni, et al.
Cancer|November 15, 2005
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemiaGiovanni Del Poeta, Maria Ilaria Del Principe, Maria Antonietta Irno Consalvo, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|January 1, 2025
Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasmsMichele Pitaro, Giovanni Antonini, Alessandro Arcovito, et al.
Mycoses|December 9, 2021
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemiaGiovangiacinto Paterno, Luca Guarnera, Raffaele Palmieri, et al.
Therapeutic Advances in Hematology|October 14, 2021
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendationsMonica Carpenedo, Erminia Baldacci, Claudia Baratè, et al.
Blood|November 9, 2002
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)Giovanni Del Poeta, Adriano Venditti, Maria Ilaria Del Principe, et al.
Journal of Immunological Methods|October 4, 2005
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevanceAntonella Zucchetto, Paolo Sonego, Massimo Degan, et al.
Future Oncology (London, England)|July 13, 2021
AMELIORATE: early intensification in <i>FLT3</i>-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trialFrancesco Mannelli, Giacomo Gianfaldoni, Paola Guglielmelli, et al.
Cancers|January 28, 2026
Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML PatientsElisa Buzzatti, Cristina Mauro, Cristiano Tesei, et al.
Cancer|July 16, 2011
Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate ProgramLuca Maurillo, Adriano Venditti, Alessandra Spagnoli, et al.
Journal of Clinical Medicine|February 26, 2025
Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of ResponseValeria Mezzanotte, Giovangiacinto Paterno, Ilaria Cerroni, et al.
Cancer|November 15, 2005
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemiaGiovanni Del Poeta, Maria Ilaria Del Principe, Maria Antonietta Irno Consalvo, et al.
Pageof 15